Get the Stockscreener App
5.5327
0.98%
-0.0573
Mannkind Corp stock is traded at $5.5327, with a volume of 477.78K.
It is down -0.98% in the last 24 hours and down -3.91% over the past month.
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.
See More
Previous Close:
$5.59
Open:
$5.6
24h Volume:
477.78K
Relative Volume:
0.10
Market Cap:
$1.70B
Revenue:
$248.37M
Net Income/Loss:
$11.74M
P/E Ratio:
110.65
EPS:
0.05
Net Cash Flow:
$18.24M
1W Performance:
+2.12%
1M Performance:
-3.91%
6M Performance:
+10.70%
1Y Performance:
-22.80%
1-Day Range:
$5.51
$5.68
1-Week Range:
$5.244
$5.72
52-Week Range:
$3.3812
$7.63
Mannkind Corp Stock (MNKD) Company Profile
Name
Mannkind Corp
Sector
Industry
Phone
818-661-5000
Address
1 CASPER STREET, DANBURY, CA
Compare MNKD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MNKD
Mannkind Corp
|
5.5345 | 1.72B | 248.37M | 11.74M | 18.24M | 0.05 |
|
VRTX
Vertex Pharmaceuticals Inc
|
423.38 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
636.02 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
442.39 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
824.56 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
181.97 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Mannkind Corp Stock (MNKD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-20-25 | Initiated | Wells Fargo | Overweight |
| Oct-10-25 | Initiated | Leerink Partners | Outperform |
| Jul-16-25 | Resumed | H.C. Wainwright | Buy |
| Apr-10-25 | Initiated | Mizuho | Outperform |
| Feb-10-25 | Initiated | Wedbush | Outperform |
| Dec-20-24 | Initiated | Wells Fargo | Overweight |
| Dec-19-24 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Sep-09-24 | Resumed | Leerink Partners | Outperform |
| Jun-13-24 | Initiated | Rodman & Renshaw | Buy |
| Oct-10-23 | Initiated | Wedbush | Outperform |
| May-14-21 | Initiated | RBC Capital Mkts | Sector Perform |
| Dec-24-19 | Initiated | Oppenheimer | Outperform |
| Oct-25-19 | Initiated | Cantor Fitzgerald | Overweight |
| May-14-19 | Initiated | BTIG Research | Buy |
| Mar-04-19 | Initiated | SVB Leerink | Outperform |
| Feb-22-19 | Initiated | SVB Leerink | Outperform |
| Feb-28-18 | Downgrade | Maxim Group | Hold → Sell |
| Nov-01-17 | Downgrade | Maxim Group | Buy → Hold |
| Oct-10-17 | Initiated | H.C. Wainwright | Buy |
| Oct-06-17 | Reiterated | Maxim Group | Buy |
| Aug-11-17 | Initiated | Maxim Group | Buy |
| May-10-16 | Reiterated | Piper Jaffray | Underweight |
| May-10-16 | Reiterated | RBC Capital Mkts | Underperform |
| Jan-06-16 | Reiterated | Piper Jaffray | Underweight |
| Jan-06-16 | Reiterated | RBC Capital Mkts | Underperform |
| Nov-04-15 | Downgrade | RBC Capital Mkts | Outperform → Underperform |
| Sep-09-15 | Downgrade | Piper Jaffray | Neutral → Underweight |
| Aug-03-15 | Reiterated | RBC Capital Mkts | Outperform |
| May-11-15 | Downgrade | JP Morgan | Neutral → Underweight |
| May-11-15 | Reiterated | MLV & Co | Hold |
| Apr-16-15 | Reiterated | RBC Capital Mkts | Outperform |
View All
Mannkind Corp Stock (MNKD) Latest News
Is MannKind Corporation stock positioned well for digital economyCEO Change & AI Forecasted Entry/Exit Points - newser.com
How analysts rate MannKind Corporation stock todayJuly 2025 Technicals & Real-Time Volume Analysis Alerts - newser.com
Technical signs of recovery in MannKind CorporationTrade Risk Assessment & Accurate Technical Buy Alerts - newser.com
Is MannKind Corporation (NNFN) stock undervalued after correction2025 Trading Recap & Growth Focused Entry Reports - newser.com
Will MannKind Corporation continue its uptrendBuy Signal & Momentum Based Trading Ideas - newser.com
Real time social sentiment graph for MannKind CorporationMarket Volume Summary & Target Return Focused Stock Picks - newser.com
Can MannKind Corporation stock continue upward trend2025 Short Interest & Community Consensus Picks - newser.com
MannKind (MNKD) to Release Quarterly Earnings on Thursday - MarketBeat
How MannKind Corporation stock responds to policy changes2025 Key Lessons & Weekly Breakout Stock Alerts - newser.com
Is MannKind Corporation stock cheap compared to fundamentals2025 Key Lessons & Technical Pattern Based Signals - newser.com
Is MannKind Corporation (NNFN) stock undervalued historically2025 Technical Patterns & Risk Controlled Swing Alerts - newser.com
MannKind Corporation to Announce Q3 2025 Financial Results and Host Webcast on November 5, 2025 - Quiver Quantitative
MannKind (Nasdaq: MNKD) to discuss third quarter 2025 results on Nov. 5 via webcast - Stock Titan
MannKind Corp. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
Can swing trading help recover from MannKind Corporation lossesProfit Target & AI Enhanced Trading Alerts - newser.com
How high can MannKind Corporation stock goJuly 2025 Fed Impact & Consistent Profit Alerts - newser.com
Is MannKind Corporation stock attractive for retirement portfoliosQuarterly Market Review & Step-by-Step Trade Execution Guides - newser.com
Will MannKind Corporation stock remain a Wall Street favorite2025 Price Action Summary & Weekly Sector Rotation Insights - fcp.pa.gov.br
Mannkind Corp Stock (MNKD) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.21%
0.74%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):